GLOBAL MED: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
GLOBAL MED
Largest movements
- Receivables within one year +€17,231
up €17,231 (+67.3%), from €25,586 to €42,816
- Cash -€1,981
down €1,981 (-16.3%), from €12,145 to €10,163
mainly Receivables within one year (-€17,231) and Trade debts (-€1,192)
- Profit (loss) carried forward +€16,442
up €16,442 (+49.2%), from €33,408 to €49,850
- Trade debts -€1,192
down €1,192 (-90.2%), from €1,322 to €130
- Gross operating margin +€11,727
up €11,727 (+128%), from €9,128 to €20,854
- Taxes +€5,437
new in 2024: €5,437
- Staff costs -€1,373
down €1,373 (-93.5%), from €1,469 to €96
- Financial income +€740
up €740 (+122%), from €608 to €1,348
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €37,730 | €52,980 | +€15,249 | +40.4% |
| Current assets | 29/58 | €37,730 | €52,980 | +€15,249 | +40.4% |
| Amounts receivable within one year | 40/41 | €25,586 | €42,816 | +€17,231 | +67.3% |
| Other amounts receivable | 41 | €25,586 | €42,816 | +€17,231 | +67.3% |
| Cash at bank and in hand | 54/58 | €12,145 | €10,163 | -€1,981 | -16.3% |
| Total equity and liabilities | 10/49 | €37,730 | €52,980 | +€15,249 | +40.4% |
| Equity | 10/15 | €36,408 | €52,850 | +€16,442 | +45.2% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Capital | 10 | €3,000 | €3,000 | = | 0.0% |
| Issued capital | 100 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €33,408 | €49,850 | +€16,442 | +49.2% |
| Amounts payable | 17/49 | €1,322 | €130 | -€1,192 | -90.2% |
| Amounts payable within one year | 42/48 | €1,322 | €130 | -€1,192 | -90.2% |
| Trade debts | 44 | €1,322 | €130 | -€1,192 | -90.2% |
| Suppliers | 440/4 | €1,322 | €130 | -€1,192 | -90.2% |
| Remuneration, social security and pensions | 62 | €1,469 | €96 | -€1,373 | -93.5% |
| Other operating charges | 640/8 | €241 | €151 | -€91 | -37.6% |
| Gross operating margin | 9900 | €9,128 | €20,854 | +€11,727 | +128% |
| Operating profit (loss) | 9901 | €7,417 | €20,607 | +€13,191 | +178% |
| Financial income | 75/76B | €608 | €1,348 | +€740 | +122% |
| Recurring financial income | 75 | €608 | €1,348 | +€740 | +122% |
| Financial charges | 65/66B | €42 | €76 | +€35 | +83.5% |
| Recurring financial charges | 65 | €42 | €76 | +€35 | +83.5% |
| Profit (loss) for the period before taxes | 9903 | €7,983 | €21,879 | +€13,896 | +174% |
| Income taxes | 67/77 | - | €5,437 | +€5,437 | |
| Profit (loss) for the period | 9904 | €7,983 | €16,442 | +€8,459 | +106% |
| Profit (loss) for the period to be appropriated | 9905 | €7,983 | €16,442 | +€8,459 | +106% |
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.